Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01938157 · ClinicalTrials.gov registry record · NA

Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
55
Enrollment target

NCT01938157 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01938157, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

Purpose: The purpose of this pilot study is to evaluate whether MRI of the breasts with diffusion-weighted MR imaging can identify features more specific for breast cancer in women at high-risk of developing breast cancer. Participants: One hundred asymptomatic women at high-risk for breast cancer recommended for a clinical breast MRI identified through the UNC Breast Clinic will be consecutively recruited for this study. Procedures (methods): Each patient will undergo a clinical breast MRI and the addition of a single 90 second diffusion weighted sequence. A reader study will be conducted at UNC after the completion of patient accrual. The images will be analysed for lesions, enhancement patterns, diffusion weighted imaging data and correlated with any pathology or 1 year follow-up MRI exam. The study information will be entered into a secure database and analyzed.

Interventions

  • PROCEDURE Diffusion-weighted MR imaging

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2013-08
Est. Completion 2017-03-09
Phase NA

What the Registry Record Tells You About NCT01938157

The ClinicalTrials.gov registry entry for NCT01938157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diffusion-weighted MR imaging is the first listed.

NCT01938157 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01938157 about?

NCT01938157 is a clinical study titled "Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study". Purpose: The purpose of this pilot study is to evaluate whether MRI of the breasts with diffusion-weighted MR imaging can identify features more specific for breast cancer in women at high-risk of developing breast cancer. Participants: One hundred asymptomatic women at high-risk for breast cancer ...

What is the current status of trial NCT01938157?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2013-08. Estimated completion is 2017-03-09.

What interventions are being tested in trial NCT01938157?

The interventions under investigation include: Diffusion-weighted MR imaging (PROCEDURE).

Who is sponsoring clinical trial NCT01938157?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.